Business
Nordson engineers precision dispensing, coating, testing and medical components.
Nordson delivered modest growth, a 26% margin and strong free cash flow from precision dispensing and medical technologies.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 3.8%OK
- Profitability — Net income grew 3.7% to $484.474M from $467.284MOK
- Cash flow — Free cash flow grew 34.4% to $661.115M from $491.783MOK
- Margins — Operating margin expanded 43 bps to 25.49%OK
- Accounting — High-margin precision-technology cash flowNote
- Insiders — 0 purchases and 10 salesWatch
Where the revenue comes from
Fiscal 2025, as NORDSON CORP reports it. History and quarterly detail are in the app.
- Industrial Precisions Solutions$1.3B
- Medical Fluid Systems$835.4M
- Advanced Technology Systems$624.5M
Leadership changes
From NORDSON CORP's own filings, the day they're filed.
- Joseph M. Rutledge · President · appointmenteff. 2025-07-14
- Daniel R. Hopgood · President · appointmenteff. 2024-04-23
- Annette Clayton · Director · appointmenteff. 2024-04-01
Latest filings
- 10-Q · Quarterly report2026-08-20
- 8-K · Company announcement2026-08-19
- 8-K · Company announcement2026-06-03
- 10-Q · Quarterly report2026-05-21
- 8-K · Company announcement2026-05-20
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about NORDSON CORP, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.